Recursion Pharmaceuticals, Inc. (RXRX)
3.61
+0.17
(+4.94%)
USD |
NASDAQ |
Sep 04, 16:00
3.645
+0.04
(+0.97%)
After-Hours: 20:00
Recursion Pharmaceuticals Net Income (Annual) : -644.76M for Dec. 31, 2025
Net Income (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -644.76M |
| December 31, 2024 | -463.66M |
| December 31, 2023 | -328.07M |
| December 31, 2022 | -239.48M |
| Date | Value |
|---|---|
| December 31, 2021 | -186.48M |
| December 31, 2020 | -87.01M |
| December 31, 2019 | -61.88M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Annual) Benchmarks
| Twist Bioscience Corp. | -77.67M |
| Absci Corp. | -115.18M |
| Novavax, Inc. | 440.30M |
| Editas Medicine, Inc. | -160.06M |
| Halozyme Therapeutics, Inc. | 316.89M |